endogenous mechanisms of inactivation of the endothelium tumor

Conditions: Breast Cancer; Colon Cancer

Summary: the role of immunity in the development of cancers, and the associated escape mechanisms, have attracted renewed interest since the publication of tests testing immunological checkpoint inhibitors. one of the steps in the probably least studied immunological response is the penetration of immunocompetent cells within the tumor across the vascular barrier. this infiltration is suggested as a prognostic and predictive marker of treatment response, particularly in triple negative her2 (human epidermal growth factor receptor-2) overexpressing breast cancers. the methods of evaluating these infiltrates are complex and have been the subject of recommendations. a better understanding of the mechanisms of infiltration of immunity cells within tumors will certainly help to better understand the impact of cancer treatments and develop new therapeutic strategies. it is this issue of vascular endothelium that dr. soncin's team is developing as part of an inca (institut national du cancer) project. the egfl7 / ve-statin (vascular endothelial-statin) gene is thought to be involved in transendothelial passage of immune cells from vascular lumen to tumor. its expression has already been studied in a series of breast cancers. other markers of endothelial activation are currently being identified. the main objective of this project will be to better understand the behavior of the endothelium in a population of breast cancer where the infiltrate in immune cells is precisely likely to play a leading role. this retrospective cohort of 250 to 300 cases treated with adjuvant and neoadjuvant will be immunologically characterized using the recommendations of salgado et al. that a multicentric team of pathologists will take ownership. this evaluation will be counter-appraised. once our cohort is immunologically characterized, our project will focus on better understanding the endothelial mechanisms involved: which cells? immunophenotyping of immunity cells. by which vessels? (measurement of densities in blood and lymphatic vessels, density in hev). by what mechanisms? do the actors identified in vitro within the inca project have an in vivo translation

the main objective of this project will be to better understand the behavior of the endothelium in a population of breast cancer where the infiltrate in immune cells is precisely likely to play a leading role. this retrospective cohort of 250 to 300 cases treated with adjuvant and neoadjuvant will be immunologically characterized using the recommendations of salgado et al., that a multicentric team of pathologists will take ownership. this evaluation will be counter-appraised. once our cohort is immunologically characterized, our project will focus on better understanding the endothelial mechanisms involved: which cells? immunophenotyping of immunity cells. by which vessels? (measurement of densities in blood and lymphatic vessels, density in hev). by what mechanisms? do the actors identified in vitro within the inca project have an in vivo translation

Eligibility criteria:
inclusion criteria: * men and women aged 18 and over * confirmed histological diagnosis of breast carcinoma at localized or metastatic stage or colorectal cancer * treated at the oscar lambret center or the henri becquerel center between 1/1/2005 and 31/12/2007 * having undergone surgery for excision of the primary tumor and / or a metastasis * resected specimen available * patients who gave their consent exclusion criteria: * history of other cancers * breast or colic tumors with other histological profiles * patient treated for breast or colonic recurrence